When Acute Ischemic Stroke Encounters an “Embolic Shower”
PU Yuehua1, DONG Pei1, JING Jing2, DONG Kehui1, LI Zixiao1,2, GONG Xiping1
1 Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China
2 China National Clinical Research Center for Neurological Diseases, Beijing 100070, China
PU Yuehua, DONG Pei, JING Jing, DONG Kehui, LI Zixiao, GONG Xiping. When Acute Ischemic Stroke Encounters an “Embolic Shower”[J]. Chinese Journal of Stroke, 2025, 20(9): 1193-1197.
[1]WANG Y J,WANG Y L,ZHAO X Q,et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J]. N Engl J Med,2013,369(1):11-19.
[2] WONG K S L,CHEN C,FU J H,et al. Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis(CLAIR study):a randomised,open-label,blinded-endpoint trial[J]. Lancet Neurol,2010,9(5):489-497.
[3] JING J,MENG X,ZHAO X Q,et al. Dual antiplatelet therapy in transient ischemic attack and minor stroke with different infarction patterns:subgroup analysis of the CHANCE randomized clinical trial[J]. JAMA Neurol,2018,75(6):
711-719.
[4] WANG Y L,ZHAO X Q,LIN J X,et al. Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack[J]. JAMA,2016,316(1):70-78.
[5]WANG Y J,MENG X,WANG A X,et al. Ticagrelor versus clopidogrel in CYP2C19 loss-of-function carriers with stroke or TIA[J]. N Engl J Med,2021,385(27):2520-2530.